Biznes i finanse

SOPHARMA AD (8/2022) Sales revenues for January 2022

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

Sofia, Bulgaria, February 7, 2022 – According to the requirements of art. 100t of LPOS, „Sopharma” AD (SFA: „BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for January 2022 the Company recorded an increase in sales of 151% compared to the same month of the previous year, incl. normalization of domestic sales with an increase of 354% due to the low base and 35% decrease in export sales.

Więcej na:,0,0,0,1

kom espi zdz

Wykorzystujemy pliki cookies.
Polityka Prywatności